| Product ID | 50564-554_71f2aff4-c5dd-4a71-b740-30a94acc9e10 |
| NDC | 50564-554 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Orphenadrine Citrate Aspirin Caffeine |
| Generic Name | Orphenadrine Citrate, Aspirin, Caffeine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1999-04-30 |
| Marketing Category | ANDA / |
| Application Number | ANDA074988 |
| Labeler Name | Jerome Stevens Pharmaceuticals, Inc. |
| Substance Name | ORPHENADRINE CITRATE; ASPIRIN; CAFFEINE |
| Active Ingredient Strength | 25 mg/1; mg/1; mg/1 |
| Pharm Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |